| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в січні 1990 (uk)
- im Januar 1990 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xineru de 1990 (ast)
- artikull shkencor i botuar më 01 janar 1990 (sq)
- scientific article published on 01 January 1990 (en)
|
| publication date
| |
| publication date
| |
| cites work
| |
| cites work
| |
| access restriction status
| |
| access restriction status
| |
| author name string
| |
| author name string
| - Y Nishiyama
- M Konishi
- K Tomita
- H Kamei
- M Hatori
- K Sugawara
- T Oki
|
| rdfs:label
| - Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity (en)
- Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity (nl)
- Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity (sq)
|
| skos:prefLabel
| - Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity (en)
- Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity (nl)
- Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity (sq)
|
| name
| - Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity (en)
- Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity (nl)
- Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity (sq)
|
| title
| |
| title
| - Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| full work available at URL
| |
| published in
| |
| full work available at URL
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| |
| online access status
| |
| online access status
| |
| is about
of | |
| is cites work
of | - Antimitotic agents of natural origin
- Development and characterization of proteasome inhibitors
- Irreversible inhibitors of serine, cysteine, and threonine proteases
- The carmaphycins: new proteasome inhibitors exhibiting an α,β-epoxyketone warhead from a marine cyanobacterium.
- 20S proteasome and its inhibitors: crystallographic knowledge for drug development
- Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology.
- Natural product inhibitors of the ubiquitin-proteasome pathway
- Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system
- The ubiquitin-proteasome pathway and proteasome inhibitors
- Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor
- Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
- Combined 3D-QSAR, molecular docking and molecular dynamics study on derivatives of peptide epoxyketone and tyropeptin-boronic acid as inhibitors against the β5 subunit of human 20S proteasome
- Proteasome inhibitors: Dozens of molecules and still counting.
- Chemical Tools To Study the Proteasome
- Proteasome inhibitors: recent advances and new perspectives in medicinal chemistry
- Lactimidomycin, a new glutarimide group antibiotic. Production, isolation, structure and biological activity
- Quality, not quantity: the role of natural products and chemical proteomics in modern drug discovery
- From bortezomib to other inhibitors of the proteasome and beyond
- Recent advances in the identification and development of 20S proteasome inhibitors
- Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones.
- Eponemycin analogues: syntheses and use as probes of angiogenesis.
- Proteasome inhibitors as therapeutic agents: current and future strategies.
- Chemical genetics: exploring the role of the proteasome in cell biology using natural products and other small molecule proteasome inhibitors
- Epoxomicin, a new antitumor agent of microbial origin
- Exploiting nature's rich source of proteasome inhibitors as starting points in drug development
- TMC-86A, B and TMC-96, new proteasome inhibitors from Streptomyces sp. TC 1084 and Saccharothrix sp. TC 1094. I. Taxonomy, fermentation, isolation, and biological activities.
- Proteasome inhibitors therapeutic strategies for cancer
- Macyranones: Structure, Biosynthesis, and Binding Mode of an Unprecedented Epoxyketone that Targets the 20S Proteasome
- Targeting the ubiquitin proteasome system: beyond proteasome inhibition.
- The UPS: a promising target for breast cancer treatment.
- Clinical and marketed proteasome inhibitors for cancer treatment
- Probing protein function with small molecules.
- The ubiquitin-proteasome system in HIV replication: potential targets for antiretroviral therapy
- Genetic basis for the biosynthesis of the pharmaceutically important class of epoxyketone proteasome inhibitors.
- Hydramycin, a new antitumor antibiotic. Taxonomy, isolation, physico-chemical properties, structure and biological activity.
- Protactin, a new antibiotic metabolite and a possible precursor of the actinomycins
- Targeted antibiotic discovery through biosynthesis-associated resistance determinants: target directed genome mining
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)